Appleton Partners Inc. MA lowered its position in shares of Clorox Co (NYSE:CLX) by 3.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,313 shares of the company’s stock after selling 113 shares during the period. Appleton Partners Inc. MA’s holdings in Clorox were worth $503,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Clorox by 0.8% in the second quarter. Vanguard Group Inc. now owns 15,541,246 shares of the company’s stock valued at $2,379,520,000 after acquiring an additional 126,624 shares in the last quarter. Parnassus Investments CA boosted its stake in Clorox by 0.4% in the third quarter. Parnassus Investments CA now owns 4,651,499 shares of the company’s stock valued at $706,423,000 after acquiring an additional 17,409 shares in the last quarter. Northern Trust Corp boosted its stake in Clorox by 0.6% in the second quarter. Northern Trust Corp now owns 2,369,859 shares of the company’s stock valued at $362,850,000 after acquiring an additional 14,792 shares in the last quarter. Morgan Stanley boosted its stake in Clorox by 8.1% in the second quarter. Morgan Stanley now owns 2,192,928 shares of the company’s stock valued at $335,759,000 after acquiring an additional 165,160 shares in the last quarter. Finally, Janus Henderson Group PLC boosted its stake in Clorox by 1.9% in the second quarter. Janus Henderson Group PLC now owns 1,804,217 shares of the company’s stock valued at $276,243,000 after acquiring an additional 33,032 shares in the last quarter. Hedge funds and other institutional investors own 78.42% of the company’s stock.
CLX has been the subject of a number of research reports. UBS Group reduced their target price on shares of Clorox from $128.00 to $125.00 and set a “sell” rating for the company in a report on Thursday, October 3rd. ValuEngine cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. JPMorgan Chase & Co. reaffirmed an “underweight” rating and issued a $137.00 target price (down from $143.00) on shares of Clorox in a report on Thursday, October 3rd. Barclays set a $138.00 target price on shares of Clorox and gave the company a “sell” rating in a report on Friday, November 1st. Finally, Bank of America reduced their target price on shares of Clorox from $165.00 to $160.00 and set a “neutral” rating for the company in a report on Thursday, October 3rd. Five analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $152.00.
In related news, SVP Michael R. Costello sold 3,225 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $161.34, for a total transaction of $520,321.50. Following the completion of the transaction, the senior vice president now directly owns 29,669 shares of the company’s stock, valued at $4,786,796.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Andrew J. Mowery sold 5,648 shares of the stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $146.29, for a total transaction of $826,245.92. Following the transaction, the senior vice president now directly owns 15,920 shares of the company’s stock, valued at $2,328,936.80. The disclosure for this sale can be found here. Insiders have sold 15,870 shares of company stock valued at $2,484,000 over the last three months. 1.14% of the stock is currently owned by corporate insiders.
Shares of NYSE:CLX opened at $148.00 on Friday. The company has a 50-day simple moving average of $149.93 and a 200-day simple moving average of $154.33. Clorox Co has a one year low of $143.58 and a one year high of $167.70. The company has a debt-to-equity ratio of 4.69, a quick ratio of 0.52 and a current ratio of 0.87. The stock has a market capitalization of $18.55 billion, a price-to-earnings ratio of 23.42, a PEG ratio of 4.73 and a beta of 0.38.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, October 31st. The company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.05. The firm had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.51 billion. Clorox had a net margin of 13.20% and a return on equity of 123.56%. The firm’s revenue for the quarter was down 3.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.62 earnings per share. As a group, research analysts forecast that Clorox Co will post 6.16 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Wednesday, October 30th will be issued a dividend of $1.06 per share. The ex-dividend date of this dividend is Tuesday, October 29th. This represents a $4.24 annualized dividend and a yield of 2.86%. Clorox’s dividend payout ratio is currently 67.09%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Read More: Short Selling Stocks and Day Traders
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.